Study Estimates Worldwide Prevalence of 25 Adult Cancers

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 2
Volume 11
Issue 2

LYON, France-A study from the International Agency for Research on Cancer (IARC) shows a higher cancer prevalence in the developed world, primarily because of longer life expectancy in richer countries (Int J Cancer 97:72-81, 2002).

LYON, France—A study from the International Agency for Research on Cancer (IARC) shows a higher cancer prevalence in the developed world, primarily because of longer life expectancy in richer countries (Int J Cancer 97:72-81, 2002).

The study examined the prevalence of 25 adult cancers for 11 world areas using data from IARC for developing countries, US SEER, and EUROCARE I. The study described the number of cancer cases diagnosed between 1986 and 1990 among individuals aged 15 or older who were still alive at the end of 1990.

Lead author Paola Pisani, reported the highest cancer prevalence in North America at 1.5%. Western Europe and Australia/New Zealand had a prevalence of 1.2% and 1.1%, respectively, followed by Japan at 1%, Eastern Europe at 0.7%, and Latin American and the Caribbean at 0.4%. The lowest prevalence (0.2%) was found in sub-Saharan Africa, the Middle East and Northern Africa, and Southeastern and South Central Asia.

Recent Videos
Retrospective and real-world registry studies may be necessary to guide clinical decision-making for rarer lymphomas with insufficient prospective data.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content